Surgical resection remains the best treatment for Stages I and II non-
small cell lung cancer. In Stage IIIA disease the use of induction the
rapy has become widespread, although evidence supporting this approach
is still preliminary. However, in subsets of patients with T3 tumours
without mediastinal nodal involvement and those with certain single s
tation, non-bulky N2 disease, surgery alone is still the preferred the
rapy. Studies show survival rates with surgery alone the same or highe
r than those achieved by most induction therapy regimens. (C) 1997 Els
evier Science Ireland Ltd.